Regulus Therapeutics Inc. (RGLS)
NASDAQ: RGLS · Real-Time Price · USD
1.400
0.00 (0.00%)
Nov 21, 2024, 4:00 PM EST - Market closed

Regulus Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
30
Market Cap
91.70M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 202010.01M3.17M46.46%
Dec 31, 20196.83M6.76M9,388.89%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
PetMed Express 259.34M
23andMe Holding Co. 193.26M
Assertio Holdings 125.76M
FONAR 102.01M
Generation Bio Co. 18.58M
Veru Inc. 14.09M
Coya Therapeutics 9.55M
Revenue Rankings